Cargando…

Telepharmacy during COVID-19: A Scoping Review

The objective of this scoping review is to summarize the implementation of telepharmacy during the surge of COVID-19. This review will focus on answering four questions: During the COVID-19 pandemic, (1) what were the various telepharmacy initiatives implemented? (2) what were the challenges faced w...

Descripción completa

Detalles Bibliográficos
Autores principales: Unni, Elizabeth J., Patel, Kanchita, Beazer, Isaac Rex, Hung, Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628897/
https://www.ncbi.nlm.nih.gov/pubmed/34842823
http://dx.doi.org/10.3390/pharmacy9040183
_version_ 1784607091581779968
author Unni, Elizabeth J.
Patel, Kanchita
Beazer, Isaac Rex
Hung, Man
author_facet Unni, Elizabeth J.
Patel, Kanchita
Beazer, Isaac Rex
Hung, Man
author_sort Unni, Elizabeth J.
collection PubMed
description The objective of this scoping review is to summarize the implementation of telepharmacy during the surge of COVID-19. This review will focus on answering four questions: During the COVID-19 pandemic, (1) what were the various telepharmacy initiatives implemented? (2) what were the challenges faced when implementing telehealth initiatives? (3) what were the strategies used by pharmacies to overcome the challenges, and (4) what were some of the innovative methods used by pharmacies to implement telepharmacy? A literature search was conducted to include publications post-March 2020 about telepharmacy implementation via PubMed Central database and Google searches. All articles were examined for inclusion or exclusion based on pre-determined criteria. A total of 33 articles were reviewed. The most commonly observed telepharmacy initiatives were virtual consultations, home delivery of medicines and patient education. Limited access to technology and lack of digital access and literacy were major barriers in the implementation of telepharmacy. New protocols were developed by healthcare systems and regulations were relaxed by countries to accommodate telepharmacy. Pharmacies that successfully implemented telepharmacy overcame these challenges through patient and pharmacist education. The review also revealed the steps that can be taken by pharmacy organizations, payers and entrepreneurs in leveraging the convenience of telepharmacy.
format Online
Article
Text
id pubmed-8628897
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86288972021-11-30 Telepharmacy during COVID-19: A Scoping Review Unni, Elizabeth J. Patel, Kanchita Beazer, Isaac Rex Hung, Man Pharmacy (Basel) Review The objective of this scoping review is to summarize the implementation of telepharmacy during the surge of COVID-19. This review will focus on answering four questions: During the COVID-19 pandemic, (1) what were the various telepharmacy initiatives implemented? (2) what were the challenges faced when implementing telehealth initiatives? (3) what were the strategies used by pharmacies to overcome the challenges, and (4) what were some of the innovative methods used by pharmacies to implement telepharmacy? A literature search was conducted to include publications post-March 2020 about telepharmacy implementation via PubMed Central database and Google searches. All articles were examined for inclusion or exclusion based on pre-determined criteria. A total of 33 articles were reviewed. The most commonly observed telepharmacy initiatives were virtual consultations, home delivery of medicines and patient education. Limited access to technology and lack of digital access and literacy were major barriers in the implementation of telepharmacy. New protocols were developed by healthcare systems and regulations were relaxed by countries to accommodate telepharmacy. Pharmacies that successfully implemented telepharmacy overcame these challenges through patient and pharmacist education. The review also revealed the steps that can be taken by pharmacy organizations, payers and entrepreneurs in leveraging the convenience of telepharmacy. MDPI 2021-11-11 /pmc/articles/PMC8628897/ /pubmed/34842823 http://dx.doi.org/10.3390/pharmacy9040183 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Unni, Elizabeth J.
Patel, Kanchita
Beazer, Isaac Rex
Hung, Man
Telepharmacy during COVID-19: A Scoping Review
title Telepharmacy during COVID-19: A Scoping Review
title_full Telepharmacy during COVID-19: A Scoping Review
title_fullStr Telepharmacy during COVID-19: A Scoping Review
title_full_unstemmed Telepharmacy during COVID-19: A Scoping Review
title_short Telepharmacy during COVID-19: A Scoping Review
title_sort telepharmacy during covid-19: a scoping review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628897/
https://www.ncbi.nlm.nih.gov/pubmed/34842823
http://dx.doi.org/10.3390/pharmacy9040183
work_keys_str_mv AT unnielizabethj telepharmacyduringcovid19ascopingreview
AT patelkanchita telepharmacyduringcovid19ascopingreview
AT beazerisaacrex telepharmacyduringcovid19ascopingreview
AT hungman telepharmacyduringcovid19ascopingreview